OC7 Maralixibat-treated patients with Alagille syndrome demonstrate event-free survival in a natural history comparison with patients with from the GALA database: application of real-world evidence analyticsBE Hansen, Willa Y. Garner, DB Mogul et al.|Abstracts|2023Cited by 0
Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemiaH. J. Lin, Anupriya Agarwal|Frontiers in Oncology|2026Cited by 0